Commit To Buy Karyopharm Therapeutics At $7.50, Earn 19.6% Annualized Using Options

Investors eyeing a purchase of Karyopharm Therapeutics Inc (KPTI) stock, but tentative about paying the going market price of $10.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $7.50 strike, which has a bid at the time of this writing of 85 cents..